# Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in Severe Aplastic Anemia Patients

> **NCT07737262** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 142 (estimated)

## Conditions studied

- Aplastic Anemia

## Interventions

- **DRUG:** N-acetylcysteine

## Key facts

- **NCT ID:** NCT07737262
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-30
- **Primary completion:** 2028-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 142 (ESTIMATED)
- **Last updated:** 2026-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07737262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07737262, "Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in Severe Aplastic Anemia Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07737262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*